Benjamin Haibe-Kains

Citée par

	Toutes	Depuis 2019
Citations	37497	22621
indice h	88	67
indice i10	205	185

4600

2300

1150

3450

200720082009201020112012201320142015201620172018201920202021202220232024161 295 545 837 988 1113 1178 1339 1557 1877 2257 2434 2965 3387 4261 4549 4331 3110

Accès public

Tout afficher

176 articles

9 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Christos SotiriouUniversité Libre de BruxellesAdresse e-mail validée de bordet.be
Christine DesmedtKU LeuvenAdresse e-mail validée de kuleuven.be
John QuackenbushHarvard T.H. Chan School of Public Health, Channing Division of Network Medicine, and Dana-FarberAdresse e-mail validée de hsph.harvard.edu
Gianluca BontempiFull professor, Machine Learning Group, Université Libre de BruxellesAdresse e-mail validée de ulb.ac.be
Hugo AertsDirector AI in Medicine (AIM) @ Harvard-MGB | Professor @ MaastrichtUAdresse e-mail validée de dfci.harvard.edu
Petr SmirnovPostdoctoral Fellow, EMBLAdresse e-mail validée de embl.de
Anna GoldenbergScientist, SickKids Research Institute; Assistant Professor Department of Computer Science, University of TorontoAdresse e-mail validée de utoronto.ca
Mauro DelorenziSIB Swiss Institute of BioinformaticsAdresse e-mail validée de unil.ch
Zhaleh SafikhaniPost doctoral fellowAdresse e-mail validée de utoronto.ca
Marc BuyseChief Scientific Officer, IDDIAdresse e-mail validée de iddi.com
Michail IgnatiadisMedical Oncology Department, Institut Jules Bordet, Université Libre de BruxellesAdresse e-mail validée de bordet.be
Patrick GrossmannPh.D. Candidate conducting research at Harvard Medical School, Dana-Farber Cancer Institute, BWHAdresse e-mail validée de jimmy.harvard.edu
Emmanuel Rios VelazquezBusiness Development Manager - Precision Health & Nutrition @imec - OnePlanet Research CenterAdresse e-mail validée de imec.nl
Andre DekkerProfessor of Clinical Data Science, MAASTRO Clinic, Maastricht University, GROW, Maastricht UMC+Adresse e-mail validée de maastro.nl
Philippe LambinProfessor of Precision Medicine, Maastricht University & Scientist ULBAdresse e-mail validée de maastrichtuniversity.nl
Fatima CardosoBreast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, PortugalAdresse e-mail validée de fundacaochampalimaud.pt
Chintan ParmarAstraZeneca (past: PathAI, Novartis, Harvard-DFCI-BWH, ISI-Kolkata, DAIICT)Adresse e-mail validée de astrazeneca.com
Philippe BedardPrincess Margaret Cancer CentreAdresse e-mail validée de uhn.ca
Sandeep K. SinghalAssociate Professor and ScientistAdresse e-mail validée de und.edu
Stefan MichielsOffice Biostatistics & Epidemiology, Gustave Roussy; Oncostat, Univ. Paris Saclay, INSERMAdresse e-mail validée de gustaveroussy.fr

Suivre

Benjamin Haibe-Kains

Scientist (Principal Investigator), Princess Margaret Cancer Centre, University Health Network

Adresse e-mail validée de uhnresearch.ca - Page d'accueil

Bioinformatics Machine Learning Genomics Computational Biology Biomedicine


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach HJWL Aerts, ER Velazquez, RTH Leijenaar, C Parmar, P Grossmann, ... Nature communications 5 (1), 4006, 2014	4991	2014
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ... Journal of the National Cancer Institute 98 (4), 262-272, 2006	2349	2006
Similarity network fusion for aggregating data types on a genomic scale B Wang, AM Mezlini, F Demir, M Fiume, Z Tu, M Brudno, B Haibe-Kains, ... Nature methods 11 (3), 333-337, 2014	1844	2014
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ... Clinical cancer research 13 (11), 3207-3214, 2007	1091	2007
CD4⁺ follicular helper T cell infiltration predicts breast cancer survival C Gu-Trantien, S Loi, S Garaud, C Equeter, M Libin, A De Wind, M Ravoet, ... The Journal of clinical investigation 123 (7), 2873-2892, 2013	1076	2013
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures P Wirapati, C Sotiriou, S Kunkel, P Farmer, S Pradervand, B Haibe-Kains, ... Breast Cancer Research 10, 1-11, 2008	1053	2008
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes C Desmedt, B Haibe-Kains, P Wirapati, M Buyse, D Larsimont, ... Clinical cancer research 14 (16), 5158-5165, 2008	952	2008
Definition of clinically distinct molecular subtypes in estrogen receptor–positive breast carcinomas through genomic grade S Loi, B Haibe-Kains, C Desmedt, F Lallemand, AM Tutt, C Gillet, P Ellis, ... Journal of clinical oncology 25 (10), 1239-1246, 2007	941	2007
CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma TP Coroller, P Grossmann, Y Hou, ER Velazquez, RTH Leijenaar, ... Radiotherapy and Oncology 114 (3), 345-350, 2015	771	2015
Robust radiomics feature quantification using semiautomatic volumetric segmentation C Parmar, E Rios Velazquez, R Leijenaar, M Jermoumi, S Carvalho, ... PloS one 9 (7), e102107, 2014	649	2014
Inconsistency in large pharmacogenomic studies B Haibe-Kains, N El-Hachem, NJ Birkbak, AC Jin, AH Beck, HJWL Aerts, ... Nature 504 (7480), 389-393, 2013	573	2013
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer S Loi, S Pommey, B Haibe-Kains, PA Beavis, PK Darcy, MJ Smyth, ... Proceedings of the National Academy of Sciences 110 (27), 11091-11096, 2013	541	2013
Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution M Chan-Seng-Yue, JC Kim, GW Wilson, K Ng, EF Figueroa, GM O’Kane, ... Nature genetics 52 (2), 231-240, 2020	495	2020
Radiomic feature clusters and prognostic signatures specific for lung and head & neck cancer C Parmar, RTH Leijenaar, P Grossmann, E Rios Velazquez, J Bussink, ... Scientific reports 5 (1), 11044, 2015	493	2015
Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling HA Azim Jr, S Michiels, PL Bedard, SK Singhal, C Criscitiello, M Ignatiadis, ... Clinical cancer research 18 (5), 1341-1351, 2012	436	2012
survcomp: an R/Bioconductor package for performance assessment and comparison of survival models MS Schröder, AC Culhane, J Quackenbush, B Haibe-Kains Bioinformatics 27 (22), 3206-3208, 2011	434	2011
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen S Loi, B Haibe-Kains, C Desmedt, P Wirapati, F Lallemand, AM Tutt, ... BMC genomics 9, 1-12, 2008	423	2008
PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor–positive breast cancer S Loi, B Haibe-Kains, S Majjaj, F Lallemand, V Durbecq, D Larsimont, ... Proceedings of the National Academy of Sciences 107 (22), 10208-10213, 2010	412	2010
Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer Y Li, L Zou, Q Li, B Haibe-Kains, R Tian, Y Li, C Desmedt, C Sotiriou, ... Nature medicine 16 (2), 214-218, 2010	399	2010
microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification B Stamatopoulos, N Meuleman, B Haibe-Kains, P Saussoy, ... Blood, The Journal of the American Society of Hematology 113 (21), 5237-5245, 2009	386	2009

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs